Breaking through barriers

Moonlight is pioneering a novel intradermal therapy to transform the lives of people living with food allergies

MOON101

MOON101 is designed with the potential to be a best-in-class differentiated treatment for peanut allergy

Funding

Moonlight Therapeutics receives multimillion dollar clinical trial grant to investigate MOON101 in peanut allergic adults and children .

Publication

MOON101, an intradermal stamp, worn for just a few minutes at a time successfully desensitized peanut-allergic mice.

Regulatory

Moonlight Therapeutics completes Pre-IND meeting with FDA for MOON101